The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells

Author： Fujiwara Jun Sowa Yoshihiro Horinaka Mano Koyama Makoto Wakada Miki Miki Tsuneharu Sakai Toshiyuki

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.5, 2012-05, pp. : 1483-1491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management Strategies for Hormone-Refractory Prostate Cancer

By Attard Gerhardt de Bono Johann S. Parker Christopher C. Horwich Alan

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite

Obesity Promotes Aerobic Glycolysis in Prostate Cancer Cells

By Cavazos David A. deGraffenried Matthew J. Apte Shruti A. Bowers Laura W. Whelan Kaitlin A. deGraffenried Linda A.

Nutrition and Cancer, Vol. 66, Iss. 7, 2014-10 ,pp. : 1179-1186

Routledge Ltd

Access to resources Recommend Favorite

Targeting the androgen receptor in hormone-refractory prostate cancer – new concepts

By Eder Iris E Haag Petra Bartsch Georg Klocker Helmut

Future Oncology, Vol. 1, Iss. 1, 2005-02 ,pp. : 93-101

Future Medicine

Access to resources Recommend Favorite

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 203-211

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced Antitumor Effects by the Coculture of Allotumor RNA-Pulsed Dendritic Cells with Autologous Cytokine-Induced Killer Cells on Hormone-Refractory Prostate Cancer

By Pang Jun Gao Xin Liu Xiaopeng Wang Kebing Zhang Yan Feng Lianqiang Zhan Hailun

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 527-534

Informa Healthcare

Access to resources Recommend Favorite